UNSPSC 85681637: Replacement of right lacrimal bone with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right lacrimal bone with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NRH3KZ

UNSPSC 85681637 Replacement of right lacrimal bone with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent state and local procurement activity. The code nominally describes a specific surgical procedure on the lacrimal bone using synthetic tissue, but the recent opportunities tagged under it reflect occupational health, benefits administration, pharmacy management, and temporary health professional staffing—none of which involve orthopedic or maxillofacial surgical procedures or tissue substitutes. The mismatch suggests either a classification error in the source data or that this code does not meaningfully track state and local procurement in its intended scope.

The six most recent opportunities linked to this code span independent medical evaluation services for public-safety pension boards (City of Phoenix, Arizona), surgical benefit carve-out networks (City of Long Beach, California), occupational medical surveillance (Washington State Department of Transportation), specialty medical services for youth in detention (Harris County, Texas), pharmacy benefit management (Collier County, Florida), and temporary health professional staffing across ancillary clinical categories (County of Santa Clara, California). None of these solicitations involve the lacrimal bone procedure or nonautologous tissue substitutes that the code nominally describes. Jurisdictions issuing under this code include state departments, counties, cities, and health systems across at least five states (Arizona, California, Florida, Texas, Washington). Without opportunities actually procuring the surgical procedure or tissue substitutes the code is intended to cover, this code does not present a clear business development opportunity in its stated scope.